34 results
8-K
EX-10.1
ACRS
Aclaris Therapeutics Inc
1 Jun 23
Entry into a Material Definitive Agreement
4:18pm
shall be subject to Landlord’s prior written approval (except in emergencies), and shall include, without limitation, any testing, investigation
8-K
EX-99.1
h3ldf
7 Dec 21
Regulation FD Disclosure
7:01am
8-K
EX-99.2
f63ybx4m4pnt4 dsb9
27 Aug 21
Regulation FD Disclosure
4:01pm
8-K
EX-1.1
15i9pvo0uo
11 Jun 21
Aclaris Announces Proposed Public Offering of Common Stock
4:01pm
S-3ASR
EX-4.3
qi6q13jx5qf1
20 May 21
Automatic shelf registration
4:56pm
8-K
EX-10.1
aqut a1k6mg8o9sg
20 May 21
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-1.1
j32y7czkmv4n
22 Jan 21
Aclaris Announces Proposed Public Offering of Common Stock
8:45am
8-K
EX-10.1
8w0pn1tn9c0s
13 Aug 20
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.2
fse3isk9v mbf6y3c
13 Aug 20
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-3.1
3cw pu3n52gh
24 Jun 20
Amendments to Articles of Incorporation or Bylaws
5:00pm
8-K
EX-10.1
j044t3sjthqb
31 Mar 20
Aclaris Therapeutics Secures $11 Million Term Loan Facility
4:15pm
8-K
EX-10.1
4i2xk abnrqw
13 Mar 20
Entry into a Material Definitive Agreement
4:01pm